Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
基本信息
- 批准号:7009321
- 负责人:
- 金额:$ 38.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Much has been learned in recent years regarding the biochemical events most critical for signal transduction mediated by numerous cell surface receptors on immune cells. A key second messenger is diacylglycerol (DAG), which is formed when engaged ITAM-bearing receptors activate the phosphatidylinositol cascade. DAG, in turn, stimulates at least two critical signaling cascades; the Ras pathway and several protein kinase C family members. Thus, understanding the formation of DAG and its metabolism is key to understanding immune cell activation. One means by which DAG function is terminated is the conversion of DAG to phosphatidic acid by DAG kinases (DGKs). This proposal focuses on DGKzeta, one of two DGKs expressed at high levels in hematopoietic cells. Our preliminary data indicate that DGKzeta is an important in vivo negative regulator of T cell and mast cell function. The experiments described in this proposal will make use of cell lines and genetically altered mice to investigate how DGKzeta serves this key role. Three specific aims will be pursued. First, we propose a cell biologic and biochemical analysis of DGKzeta to determine its subcellular localization and features most critical for affecting signaling pathways. The second aim will investigate the impact of DGKzeta deficiency on in vivo T cell function and the third aim will examine similar questions in the mast cell compartment. Both aims 2 and 3 will extend the structure/function analysis to determine features of this enzyme most essential for responses to immunologic challenges. We anticipate that this work will shed additional light on the complex regulation of T cell and mast cell function and will hopefully suggest novel approaches to modulate activity of these cell types.
描述(由申请人提供):近年来,关于免疫细胞上许多细胞表面受体介导的信号转导最关键的生化事件,已经学到了很多。一个关键的第二信使是二酰甘油(DAG),它是当ITAM受体激活磷脂酰肌醇级联反应时形成的。反过来,DAG刺激至少两个关键的信号级联反应:RAS途径和几个蛋白激酶C家族成员。因此,了解DAG的形成和代谢是了解免疫细胞激活的关键。DAG功能终止的一种方式是通过DAG激酶(DGK)将DAG转化为磷脂酸。这项建议关注的是DGKzeta,它是两种在造血细胞中高水平表达的DGKzeta之一。我们的初步数据表明,DGKzeta是体内重要的T细胞和肥大细胞功能的负调节因子。这项提案中描述的实验将利用细胞系和转基因小鼠来研究DGKzeta是如何发挥这一关键作用的。将追求三个具体目标。首先,我们提出了DGKzeta的细胞生物学和生化分析,以确定其亚细胞定位和最关键的影响信号通路的特征。第二个目标将研究DGKzeta缺乏对体内T细胞功能的影响,第三个目标将研究肥大细胞室中的类似问题。AIMS 2和AIMS 3都将扩展结构/功能分析,以确定对免疫挑战的反应最关键的这种酶的特征。我们预计,这项工作将进一步阐明T细胞和肥大细胞功能的复杂调控,并有望提出新的方法来调节这些细胞类型的活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY A. KORETZKY其他文献
GARY A. KORETZKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY A. KORETZKY', 18)}}的其他基金
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
- 批准号:
8093168 - 财政年份:2010
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of Integrin Signaling by Adapter Proteins
接头蛋白对整合素信号传导的调节
- 批准号:
7323902 - 财政年份:2007
- 资助金额:
$ 38.69万 - 项目类别:
SIGNAL TRANSDUCTION IN THE IMMUNE SYSTEM-FASEB CONF.
免疫系统中的信号转导 - FASEB CONF。
- 批准号:
6940539 - 财政年份:2005
- 资助金额:
$ 38.69万 - 项目类别:
2005 Immunochemistry and Immunobiology Gordon Conference
2005年免疫化学和免疫生物学戈登会议
- 批准号:
6993506 - 财政年份:2005
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
- 批准号:
7342494 - 财政年份:2004
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of PMN activation by SLP-76, PRAM-1 and ADAP
SLP-76、PRAM-1 和 ADAP 对 PMN 激活的调节
- 批准号:
7225954 - 财政年份:2004
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
- 批准号:
7172927 - 财政年份:2004
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of T Cell and Mast Cell Function by DGKzeta
DGKzeta 对 T 细胞和肥大细胞功能的调节
- 批准号:
6845716 - 财政年份:2004
- 资助金额:
$ 38.69万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Discovery Grants Program - Individual